CURX

Curanex Pharmaceuticals Inc Common Stock

NASDAQ: CURX · HEALTHCARE · BIOTECHNOLOGY

$4.40

-4.35% today

Updated 2026-09-18

Market cap

$7.14M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-7.38

Dividend yield

—

52W range

$4 – $184

Volume

0.1M

Market cap

$7.14M

P/E ratio

—

P/S ratio

—

EPS (TTM)

$-7.38

Dividend yield

—

52W range

$4 – $184

Volume

0.1M

WallStSmart proprietary scores

out of 100

Grade: F

Strong Sell

Investment rating

4.3

Growth

8.5

Quality

3.0

Profitability

5.0

Valuation

C+

3/9

Piotroski F-Score

Weak

18.0

Altman Z-Score

Safe zone

—

Industry rank

—

View all highly rated stocks (75+) →253 stocks currently score above 75

Price targets

Analyst target

—

12-Month target

—

Intrinsic (DCF)

—

Margin of safety

—

Price chart

Stock snapshot

Strengths

+ Altman Z 18.01 — safe zone

+ Debt/equity 0.06x — low leverage

Risks

- Piotroski 3/9 — weak financial health

- Thin margins at 0.00%

- Negative free cash flow $-1.08M

Key financials

Revenue Net Income Free Cash Flow

Metric	2022	2023	2024	2025	TTM
Revenue	$26000.00	$0.00	$0.00	$0.00	$0.00
Net income	$-20233.00	$-19198.00	$-361506.00	$-4.23M	$-3.29M
EPS	—	—	—	—	$-7.38
Free cash flow	$3336.00	$-120.00	$-555580.00	$-10.48M	$-1.08M
Profit margin	-77.82%	—	—	—	—

Peer comparison

Company	Mkt Cap	Score	Growth	Profit	Value	Quality	MoS	Rating
CURX	$7.14M	23	4.3	3.0	5.0	8.5	—	Avoid
LLY	$994.92B	76	9.3	10.0	5.0	6.0	—	Strong Buy
JNJ	$640.02B	59	4.7	8.5	3.7	5.5	—	Buy
ABBV	$454.36B	73	6.7	8.5	4.0	5.0	-73.51%	Strong Buy
MRK	$355.10B	36	4.0	4.5	2.0	5.0	-77.20%	Hold
UNH	$340.27B	62	7.3	5.5	4.7	5.5	-15.43%	Buy

Smart narrative

Curanex Pharmaceuticals Inc Common Stock trades at $4.40. Our Smart Value Score of 23/100 indicates the stock is weak. The company scores 3/9 on the Piotroski F-Score. With an Altman Z-Score of 18.01, it sits in the safe zone.

Frequently asked questions

What is Curanex Pharmaceuticals Inc Common Stock's stock price?

Curanex Pharmaceuticals Inc Common Stock (CURX) trades at $4.40.

Is Curanex Pharmaceuticals Inc Common Stock overvalued?

Curanex Pharmaceuticals Inc Common Stock carries a Smart Value Score of 23/100 (Grade F), which we rate Strong Sell. That score blends growth, quality, and valuation into one read.

Altman Z-Score?

Curanex Pharmaceuticals Inc Common Stock's Altman Z-Score is 18.01, which places it in the safe zone. The Altman Z-Score gauges bankruptcy risk from profitability, leverage, and asset efficiency, and a higher reading points to lower financial distress risk.

Company info

SectorHEALTHCARE

IndustryBIOTECHNOLOGY

CountryUSA

ExchangeNASDAQ

CurrencyUSD

Quick metrics

P/S ratio—

ROE-89.59%

Beta—

50D MA$4.35

200D MA$6.76

Shares out0.00B

Float0.00B

Short ratio—

Avg volume0.1M

Performance

1 week—

1 month—

3 months—

YTD—

1 year—

3 years—

5 years—

Compare

CURX vs LLY →CURX vs JNJ →CURX vs ABBV →Stock screener →